Skip to main content
SpringerLink
Log in

Pre-procedural Assessments and Considerations

  • Chapter
  • First Online:
Anesthesia Management for Electroconvulsive Therapy

Abstract

Electric stimulus and seizure during the electroconvulsive therapy (ECT) make patients various impacts so that it is recommended to perform ECT under general anesthesia (modified ECT: mECT). To optimize the anesthetic management of patients under mECT, it is important to understand the physiologic responses to the electrical stimulus, even though under general anesthesia. And also, the early assessment of patient’s physical condition is required, since there may be some physical problems because of psychiatric disorders, medications and others in patients required for mECT. Therefore, pre-procedure assessment, including inquiry, check of medications and usual examinations, is also important and required as normal general anesthesia. If needed, special examinations and special monitor during anesthesia should be ordered. In this chapter, some points for pre-procedure assessments and conditions for mECT were described.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Khan A, Mirolo MH, Hughes D, Bierut L. Electroconvulsive therapy. Psychiatr Clin North Am. 1993;16:497–513.

    CAS  PubMed  Google Scholar 

  2. Thompson JW, Weiner RD, Myers CP. Use of ECT in the United States in 1975, 1980, and 1986. Am J Psychiatry. 1994;151:1657–61.

    Article  CAS  PubMed  Google Scholar 

  3. American Psychiatric Association Committee on Electroconvulsive Therapy. The practice of electroconvulsive therapy. 2nd ed. Washington, DC: American Psychiatric Association; 2001.

    Google Scholar 

  4. Ding Z, White PF. Anesthesia for electroconvulsive therapy. Anesth Analg. 2002;94:1351–64.

    Article  PubMed  Google Scholar 

  5. Pagnin D, de Queiroz V, Pini S, Cassano GB. Efficacy of ECT in depression: a meta-analytic review. J ECT. 2004;20:13–20.

    Article  PubMed  Google Scholar 

  6. Kellner CH, Tobias KG, Jakubowski LM, Ali Z, Istafanous RM. Electroconvulsive therapy for an urgent social indication. J ECT. 2009;25:274–5.

    Article  PubMed  Google Scholar 

  7. The American Psychiatric Association Task Force on Electroconvulsive Therapy. Ther practice of electroconvulsive therapy: recommendations for treatment, training, and privileging: a task force report of the American Psychiatric Association. Washington, DC: American Psychiatric Association; 1990. p. 6.

    Google Scholar 

  8. O’Flaherty D, Husain MM, Moore M, Wolff TR, Sills S, Giesecke AH. Circulatory responses during electroconvulsive therapy. The comparative effects of placebo, esmolol and nitroglycerin. Anaesthesia. 1992;47:563–7.

    Article  PubMed  Google Scholar 

  9. Weinger MB, Partridge BL, Hauger R, Mirow A. Prevention of the cardiovascular and neuroendocrine response to electroconvulsive therapy: I. Effectiveness of pretreatment regimens on hemodynamics. Anesth Analg. 1991;73:556–62.

    Article  CAS  PubMed  Google Scholar 

  10. Weinger MB, Partridge BL, Hauger R, Mirow A, Brown M. Prevention of the cardiovascular and neuroendocrine response to electroconvulsive therapy: II. Effects of pretreatment regimens on catecholamines, ACTH, vasopressin, and cortisol. Anesth Analg. 1991;73:563–9.

    Article  CAS  PubMed  Google Scholar 

  11. Partridge BL, Weinger MB, Hauger R. Is the cardiovascular response to electroconvulsive therapy due to the electricity or the subsequent convulsion? Anesth Analg. 1991;72:706–9.

    Article  CAS  PubMed  Google Scholar 

  12. Saito S. Anesthesia management for electroconvulsive therapy: hemodynamic and respiratory management. J Anesth. 2005;19:142–9.

    Article  PubMed  Google Scholar 

  13. Simpson KH, Lynch L. Anaesthesia and electroconvulsive therapy (ECT). Anaesthesia. 1998;53:615–7.

    Article  CAS  PubMed  Google Scholar 

  14. Lyndon W, Wilson C. Anesthesia for electroconvulsive therapy – time for a review? Brain Stimul. 2015;8:985–6.

    Article  PubMed  Google Scholar 

  15. http://www.anesth.or.jp/guide/pdf/monitor2.pdf

  16. Joynt KE, Whellan DJ, O’Connor CM. Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry. 2003;54:248–61.

    Article  PubMed  Google Scholar 

  17. Wulsin LR, Vaillant GE, Wells VE. A systematic review of the mortality of depression. Psychosom Med. 1999;61:6–17.

    Article  CAS  PubMed  Google Scholar 

  18. Lichtman JH, Bigger JT Jr, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lespérance F, Mark DB, Sheps DS, Taylor CB, Froelicher ES. AHA science advisory. Depression and coronary heart disease. Recommendations for screening, referral, and treatment. A science advisory from the American Heart Association Prevention Committee to the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care Outcomes Research. Endorsed by the American Psychiatric Association. Prog Cardiovasc Nurs. 2009;24:19–26.

    Google Scholar 

  19. Lichtman JH, Bigger JT Jr, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lespérance F, Mark DB, Sheps DS, Taylor CB, Froelicher ES, American Heart Association Prevention Committee of the Council on Cardiovascular Nursing; American Heart Association Council on Clinical Cardiology, American Heart Association Council on Epidemiology and Prevention, American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research, American Psychiatric Association. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008;118:1768–75.

    Google Scholar 

  20. Braverman B, McCarthy RJ, Ivankovich AD. Vasopressor challenges during chronic MAOI or TCA treatment in anesthetized dogs. Life Sci. 1987;40:2587–95.

    Article  CAS  PubMed  Google Scholar 

  21. Drugs for psychiatric disorders. Med Lett Drugs Ther. 1991;33:43–50.

    Google Scholar 

  22. Ray WA, Meredith S, Thapa PB, Hall K, Murray KT. Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther. 2004;75:234–41.

    Article  CAS  PubMed  Google Scholar 

  23. Cohen HW, Gibson G, Alderman MH. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med. 2000;108:2–8.

    Article  CAS  PubMed  Google Scholar 

  24. Tata LJ, West J, Smith C, Farrington P, Card T, Smeeth L, Hubbard R. General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart. 2005;91:465–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Sicouri S, Antzelevitch C. Sudden cardiac death secondary to antidepressant and antipsychotic drugs. Expert Opin Drug Saf. 2008;7:181–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Andersohn F, Schade R, Suissa S, Garbe E. Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry. 2009;166:591–8.

    Article  PubMed  Google Scholar 

  27. Katon W, Fan MY, Unützer J, Taylor J, Pincus H, Schoenbaum M. Depression and diabetes: a potentially lethal combination. J Gen Intern Med. 2008;23:1571–5.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Ray WA, Meredith S, Thapa PB, Meador KG, Hall K, Murray KT. Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry. 2001;58:1161–7.

    Article  CAS  PubMed  Google Scholar 

  29. Goldman LS. Medical illness in patients with schizophrenia. J Clin Psychiatry. 1999;60:s10–5.

    Google Scholar 

  30. Dworkin RH. Pain insensitivity in schizophrenia: a neglected phenomenon and some implications. Schizophr Bull. 1994;20:235–48.

    Article  CAS  PubMed  Google Scholar 

  31. Adler LE, Griffith JM. Concurrent medical illness in the schizophrenic patient. Epidemiology, diagnosis, and management. Schizophr Res. 1991;4:91–107.

    Article  CAS  PubMed  Google Scholar 

  32. Haddad PM, Anderson IM. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs. 2002;62:1649–71.

    Article  CAS  PubMed  Google Scholar 

  33. Glassman AH. Schizophrenia, antipsychotic drugs, and cardiovascular disease. J Clin Psychiatry. 2005;66:s5–10.

    Article  Google Scholar 

  34. Glassman AH, Bigger Jr JT. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry. 2001;158:1774–82.

    Article  CAS  PubMed  Google Scholar 

  35. Kuehn BM. FDA warns antipsychotic drugs may be risky for elderly. JAMA. 2005;293:2462.

    Article  CAS  PubMed  Google Scholar 

  36. de Leon J, Diaz FJ, Rogers T, Browne D, Dinsmore L. Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders. Schizophr Res. 2002;56:47–54.

    Article  PubMed  Google Scholar 

  37. Copeland LA, Mortensen EM, Zeber JE, Pugh MJ, Restrepo MI, Dalack GW. Pulmonary disease among inpatient decedents: impact of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:720–6.

    Article  PubMed  Google Scholar 

  38. Chafetz L, White MC, Collins-Bride G, Nickens J. The poor general health of the severely mentally ill: impact of schizophrenic diagnosis. Community Ment Health J. 2005;41:169–84.

    Article  PubMed  Google Scholar 

  39. Nagamine T. Serum substance P levels in patients with chronic schizophrenia treated with typical or atypical antipsychotics. Neuropsychiatr Dis Treat. 2008;4:289–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Kudoh A, Katagai H, Takase H, Takazawa T. Effect of preoperative discontinuation of antipsychotics in schizophrenic patients on outcome during and after anaesthesia. Eur J Anaesthesiol. 2004;21:414–6.

    Article  CAS  PubMed  Google Scholar 

  41. Kudoh A, Ishihara H, Matsuki A. Pituitary-adrenal and parasympathetic function in chronic schizophrenic patients with postoperative ileus or hypotension. Neuropsychobiology. 1999;39:125–30.

    Article  CAS  PubMed  Google Scholar 

  42. Kudoh A, Kudo T, Ishihara H, Matsuki A. Depressed pituitary-adrenal response to surgical stress in chronic schizophrenic patients. Neuropsychobiology. 1997;36:112–6.

    Article  CAS  PubMed  Google Scholar 

  43. Applegate RJ. Diagnosis and management of ischemic heart disease in the patient scheduled to undergo electroconvulsive therapy. Convuls Ther. 1997;13:128–244.

    CAS  PubMed  Google Scholar 

  44. Saito S, Kadoi Y, Iriuchijima N, Obata H, Arai K, Morita T, Goto F. Reduction of cerebral hyperemia with anti-hypertensive medication after electroconvulsive therapy. Can J Anaesth. 2000;47:767–74.

    Article  CAS  PubMed  Google Scholar 

  45. Wijeratne C, Shome S. Electroconvulsive therapy and subdural hemorrhage. J ECT. 1999;15:275–9.

    Article  CAS  PubMed  Google Scholar 

  46. Nisijima K, Ishiguro T. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases. J ECT. 1999;15:158–63.

    Article  CAS  PubMed  Google Scholar 

  47. Kelly D, Brull SJ. Neuroleptic malignant syndrome and mivacurium: a safe alternative to succinylcholine? Can J Anaesth. 1994;41:845–9.

    Article  CAS  PubMed  Google Scholar 

  48. Echevarría Moreno M, Martin Muñoz J, Sanchez Valderrabanos J, Vázquez Gutierrez T. Electroconvulsive therapy in the first trimester of pregnancy. J ECT. 1998;14:251–4.

    PubMed  Google Scholar 

  49. Tezuka N, Egawa H, Fukagawa D, Yamaguchi S, Hamaguchi S, Kitajima T, Minami J. Assessment of QT interval and QT dispersion during electroconvulsive therapy using computerized measurements. J ECT. 2010;26:41–6.

    Article  PubMed  Google Scholar 

  50. Yamaguchi S, Nagao M, Ikeda T, Fukagawa D, Kimura Y, Kitajima T, Minami J. QT dispersion and rate-corrected QT dispersion during electroconvulsive therapy in elderly patients. J ECT. 2011;27:183–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, School of Medicine, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan

    Shigeki Yamaguchi & Toshifumi Takasusuki

Authors
  1. Shigeki Yamaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toshifumi Takasusuki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shigeki Yamaguchi .

Editor information

Editors and Affiliations

  1. Gunma University Graduate School of Med., Department of Anesthesiology, Maebashi, Gunma, Japan

    Shigeru Saito

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Japan

About this chapter

Cite this chapter

Yamaguchi, S., Takasusuki, T. (2016). Pre-procedural Assessments and Considerations. In: Saito, S. (eds) Anesthesia Management for Electroconvulsive Therapy. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55717-3_1

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-55717-3_1

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-55716-6

  • Online ISBN: 978-4-431-55717-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation